Two Drugmakers Dominate Obesity Boom, Tiny Fund Holds Both
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
This intro explains what a high index level may indicate in terms of trend strength, momentum, and potential market overheating.
25,925 articlesTwo drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Sen. Mitch McConnell disclosed that a fall caused his hospitalization and that he is in rehab, ending weeks of frenzi...
A year after XRP surged to $3.65, ripple (xrp) peaked $3.65 remains a milestone. Today, the token is far lower as reg...
Tax season doesn't have to cost you money. This guide explains how to file your taxes for free in 2026, compares IRS ...
The CEO of a $1B AI unicorn pushes back on doom-laden talk about job loss, arguing that funding cycles and strategic ...
Mullen’s share path remains highly uncertain as the EV market shifts and capital needs loom. This report maps potenti...
Prediction markets for Bitcoin show a cautious view, but there may be a stronger upside catalyst many are overlooking...
Stratasys is stepping into 2025 with a focused plan to diversify revenue, improve margins, and scale software-led ser...
Ferrari's latest results underscore its asset-like status, delivering strong cash flow while preparing for an electri...
Airbnb's path through 2026 to 2030 hinges on travel demand, new services, and pricing power. This report lays out sce...
Two clean-economy names, two distinct plays: Brookfield Renewable and Clean Harbors offer differing traps and rewards...
A Goldman Sachs survey finds most small businesses are using AI with optimism about revenue gains, but only a minorit...